Flagship Harbor Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-70
Closed -$5K – 759
2020
Q3
$5K Hold
70
– – ﹤0.01% 1519
2020
Q2
$5K Hold
70
– – ﹤0.01% 1561
2020
Q1
$4K Sell
70
-36
-34% -$3.32K ﹤0.01% 1452
2019
Q4
$12K Buy
106
+56
+112% +$5.97K ﹤0.01% 1269
2019
Q3
$4K Hold
50
– – ﹤0.01% 1536
2019
Q2
$4K Buy
+50
New +$4.11K ﹤0.01% 1540

Other funds holding CNMD

Flagship Harbor Advisors's CNMD Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of CONMED (CNMD) in Q4 2020, closing a stake of 70 shares — an estimated $5K sold.

Flagship Harbor Advisors first reported a position in CNMD in Q2 2019 and held it in 6 quarters. The position peaked at $12K in Q4 2019. 249 funds tracked by Wall St. Rank hold CNMD as of Q4 2020.

  • Flagship Harbor Advisors reported no remaining CONMED position as of Q4 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 70 CONMED shares in Q4 2020, an estimated $5K.
  • Flagship Harbor Advisors first reported a position in CONMED in Q2 2019 and held it in 6 quarters.
  • Flagship Harbor Advisors's CONMED position peaked at $12K in Q4 2019.
  • 249 funds tracked by Wall St. Rank held CONMED as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.